A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses

BMC Medicine

Volumn 9, Issue , 2011, Pages

  Ling, Xuefeng B ^a   Lau, Kenneth ^a   Kanegaye, John T ^b,c   Pan, Zheng ^d   Peng, Sihua ^a   Ji, Jun ^a   Liu, Gigi ^a   Sato, Yuichiro ^b   Yu, Tom T S ^a   Whitin, John C ^a   Schilling, James ^a   Burns, Jane C ^b   Cohen, Harvey J ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COL16A1 PROTEIN; COL1A1 PROTEIN; COL23A1 PROTEIN; COL3A1 PROTEIN; COL9A3 PROTEIN; COLEC12 PROTEIN; EMID1 PROTEIN; PEPTIDES AND PROTEINS; Q6ZSL6 PROTEIN; UMOD PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TRANSCRIPTOME;

ARTICLE; CELL DIFFERENTIATION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FEVER; GENE EXPRESSION; GENETIC ALGORITHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEOTIDE SEQUENCE; PEPTIDOMICS; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEIN URINE LEVEL; URINALYSIS; ADULT; ALGORITHM; AREA UNDER THE CURVE; BLOOD; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEINURIA; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; URINE;

ADULT; ALGORITHMS; AREA UNDER CURVE; BIOLOGICAL MARKERS; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE ANALYSIS; PROTEINURIA; PROTEOMICS; ROC CURVE; TRANSCRIPTOME;

EID: 82655162522     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-9-130     Document Type: Article

References (34)

1. Burns JC. Kawasaki Disease update. Indian J Pediatr 2009, 76:71-76. 10.1007/s12098-009-0031-3, 19391005.
2. Gedalia A. Kawasaki disease: 40 years after the original report. Curr Rheumatol Rep 2007, 9:336-341. 10.1007/s11926-007-0053-7, 17688844.
3. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974, 54:271-276.
4. Morens DM, Nahmias AJ. Kawasaki disease: a 'new' pediatric enigma. Hosp Pract 1978, 13:109-112, 119-120.
5. Biezeveld M, Geissler J, Merkus M, Kuipers IM, Ottenkamp J, Kuijpers T. The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol 2007, 147:106-111. 1810456, 17177969.
6. Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol 2003, 23:576-581. 10.1161/01.ATV.0000065385.47152.FD, 12692003.
7. Imayoshi M, Yamamoto S, Watanabe M, Nishimura S, Tashiro K, Zaitsu M, Tasaki H, Kimoto M, Hamasaki Y, Ishii E. Expression of CD180, a toll-like receptor homologue, is up-regulated in children with Kawasaki disease. J Mol Med 2006, 84:168-174. 10.1007/s00109-005-0010-8, 16389554.
8. Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, Brown PO, Burns JC, Relman DA. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol 2007, 8:R261. 10.1186/gb-2007-8-12-r261, 2246263, 18067656.
9. Popper SJ, Watson VE, Shimizu C, Kanegaye JT, Burns JC, Relman DA. Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis 2009, 200:657-666. 10.1086/603538, 2878183, 19583510.
10. Biezeveld MH, van Mierlo G, Lutter R, Kuipers IM, Dekker T, Hack CE, Newburger JW, Kuijpers TW. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol 2005, 141:183-188. 10.1111/j.1365-2249.2005.02829.x, 1809423, 15958085.
11. Ohno T, Yuge T, Kariyazono H, Igarashi H, Joh-o K, Kinugawa N, Kusuhara K, Hara T. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2002, 161:105-111. 10.1007/s00431-001-0860-1, 11954744.
12. Anderson MS, Burns J, Treadwell TA, Pietra BA, Glode MP. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J 2001, 20:698-702. 10.1097/00006454-200107000-00011, 11465843.
13. Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, Kawamura Y, Mori K, Sekine I, Yoshioka S. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997, 108:446-450. 10.1046/j.1365-2249.1997.3852128.x, 1904674, 9182890.
14. Koren G, Silverman E, Sundel R, Edney P, Newburger JW, Klein J, Robieux I, Laxer R, Giesbrecht E, Burns JC. Decreased protein binding of salicylates in Kawasaki disease. J Pediatr 1991, 118:456-459. 10.1016/S0022-3476(05)82168-7, 1999792.
15. Shen-Orr SS, Tibshirani R, Khatri P, Bodian DL, Staedtler F, Perry NM, Hastie T, Sarwal MM, Davis MM, Butte AJ. Cell type-specific gene expression differences in complex tissues. Nat Methods 2010, 7:287-289. 10.1038/nmeth.1439, 20208531.
16. Decramer S, de Peredo AG, Breuil B, Mischak H, Monsarrat B, Bascands J-L, Schanstra JP. Urine in Clinical Proteomics. Mol Cell Proteomics 2008, 7:1850-1862. 10.1074/mcp.R800001-MCP200, 18667409.
17. Ling XB, Mellins ED, Sylvester KG, Cohen HJ. Urine peptidomics for clinical biomarker discovery. Adv Clin Chem 2010, 51:181-213.
18. Sigdel T, Ling XB, Lau K, Li L, Schilling J, Sarwal M. Urinary peptidomic analysis identifies potential biomarkers for acute rejection of renal transplantation. Clin Proteomics 2009, 5:103-113.
19. Ling XB, Sigdel TK, Lau K, Ying L, Lau I, Schilling J, Sarwal MM. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol 2010, 21:646-653. 10.1681/ASN.2009080876, 2844301, 20150539.
20. Ling XB, Lau K, Deshpande C, Park JL, Milojevic D, Macaubas C, Xiao C, Lopez-Avila V, Kanegaye J, Burns JC, Cohen H, Schilling J, Mellins ED. Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics 2010, 6:175-193. 10.1007/s12014-010-9058-8, 2970804, 21124648.
21. Oza NC. Ensemble data mining. 2006, NASA Ames Research Center. Moffett Field, CA, USA.
22. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, . Committee on Rheumatic Fever, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004, 114:1708-1733. 10.1542/peds.2004-2182, 15574639, Committee on Rheumatic Fever, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
23. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39:561-577.
24. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005, 21:3940-3941. 10.1093/bioinformatics/bti623, 16096348.
25. Wu X, Watson M. CORNA: testing gene lists for regulation by microRNAs. Bioinformatics 2009, 25:832-833. 10.1093/bioinformatics/btp059, 2654799, 19181683.
26. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
27. Lin Z, Fitzgerald JB, Xu J, Willers C, Wood D, Grodzinsky AJ, Zheng MH. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res 2008, 26:1230-1237. 10.1002/jor.20523, 18404652.
28. Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child 2006, 91:847-851. 10.1136/adc.2005.087437, 2066006, 16990356.
29. Peng Q, Zhou TF, Chen CH, Hua YM, Liu HM, Hong H, Zhang LY, Wu Q. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease]. Zhonghua Er Ke Za Zhi 2005, 43:676-680.
30. Chua MS, Sarwal MM. Microarrays: new tools for transplantation research. Pediatr Nephrol 2003, 18:319-327.
31. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001, 104:860-863. 10.1161/hc3301.095286, 11514369.
32. Matsuyama T. Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis. Pediatr Int 1999, 41:239-245. 10.1046/j.1442-200x.1999.01061.x, 10365570.
33. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006, 116:271-284. 1323259, 16395409.
34. Macaubas C, Nguyen K, Deshpande C, Phillips C, Peck A, Lee T, Park JL, Sandborg C, Mellins ED. Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states. Clin Immunol 2010, 134:206-216. 10.1016/j.clim.2009.09.010, 2818241, 19879195.